TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) Investor Investigation Concerning Potential Breaches Of Fiduciary Duties Announced

  • If you purchased shares of Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Cytori Therapeutics Inc.
Security
NASDAQ: CYTX

Summary

August 21, 2014 (Shareholders Foundation) - An investigation on behalf of investors in Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Cytori Therapeutics Inc.

The investigation by a law firm concerns whether certain Cytori Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Cytori Therapeutics Inc. reported that its annual Total Revenue declined from $14.50 million in 2012 to $12.20 million in 2013 and that its Net loss declined from $32.28 million in 2012 to $26.18 million in 2013. Shares of Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) declined from $4.75 per share in September 2012 to as low as $1.38 per share on August 21, 2014.

Start Monitoring Your Investments